HQ: United States
Founded in 2018, Navega Therapeutics Inc. is a preclinical stage company pursuing a radically different approach to treat chronic pain and tackle the opioid epidemic. Our gene therapy platform has the advantage of being highly specific and long-lasting, which has not been achieved by small molecules thus far. Our pipeline includes different types of pain to improve the quality of life of millions of patients.
Offered / Sold Amount
Reported by Press*
Other Relevant Investments
*More data available at: [CB Insights] [CrunchBase] [PitchBook]